Brian J O'connell, MD | |
1707 W Charleston Blvd Ste 160, Las Vegas, NV 89102-2354 | |
(702) 671-5150 | |
(702) 671-2259 |
Full Name | Brian J O'connell |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 18 Years |
Location | 1707 W Charleston Blvd Ste 160, Las Vegas, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730494741 | NPI | - | NPPES |
1832R | Other | NC | BCBS NC |
1730494741 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 2013-02230 (North Carolina) | Secondary |
208600000X | Surgery | 268463 (Massachusetts) | Secondary |
2086S0127X | Surgery - Trauma Surgery | 20465 (Nevada) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Medical Center | Las vegas, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Unlv Medicine | 4183991458 | 145 |
News Archive
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
The shortage of primary care physicians could prove a major challenge to health reform. To make matters worse, some doctors are considering early retirement because of the high cost of practicing medicine.
A powerful clue has emerged in a long-running mystery about how the cells of myelodysplastic syndrome (MDS) manage to outcompete normal blood cells to cause a disease state that often leads to leukemia, according to a study published online April 20, 2020, in Nature Immunology.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
Alzheimer's disease is more common in rural Appalachian Ohio communities than in other rural areas in the state - raising concerns about access to early, specialized care in a region where many residents face struggles getting the medical care they need, a new study has found.
› Verified 2 days ago
Entity Name | Unlv Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407397235 PECOS PAC ID: 4183991458 Enrollment ID: O20170517002454 |
News Archive
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
The shortage of primary care physicians could prove a major challenge to health reform. To make matters worse, some doctors are considering early retirement because of the high cost of practicing medicine.
A powerful clue has emerged in a long-running mystery about how the cells of myelodysplastic syndrome (MDS) manage to outcompete normal blood cells to cause a disease state that often leads to leukemia, according to a study published online April 20, 2020, in Nature Immunology.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
Alzheimer's disease is more common in rural Appalachian Ohio communities than in other rural areas in the state - raising concerns about access to early, specialized care in a region where many residents face struggles getting the medical care they need, a new study has found.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Brian J O'connell, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-3050 | Brian J O'connell, MD 1707 W Charleston Blvd Ste 160, Las Vegas, NV 89102-2354 Ph: (702) 671-5150 |
News Archive
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
The shortage of primary care physicians could prove a major challenge to health reform. To make matters worse, some doctors are considering early retirement because of the high cost of practicing medicine.
A powerful clue has emerged in a long-running mystery about how the cells of myelodysplastic syndrome (MDS) manage to outcompete normal blood cells to cause a disease state that often leads to leukemia, according to a study published online April 20, 2020, in Nature Immunology.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
Alzheimer's disease is more common in rural Appalachian Ohio communities than in other rural areas in the state - raising concerns about access to early, specialized care in a region where many residents face struggles getting the medical care they need, a new study has found.
› Verified 2 days ago
Moungar Elton Cooper, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6240 N Durango Dr Ste 120, Las Vegas, NV 89149 Phone: 702-791-7855 | |
Dr. Ikram U Khan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 465, Las Vegas, NV 89109 Phone: 702-595-1059 Fax: 702-734-0548 | |
Colton Ty Lee, MD Surgery Medicare: Medicare Enrolled Practice Location: 8930 W Sunset Rd Ste 300, Las Vegas, NV 89148 Phone: 702-757-4724 Fax: 702-258-7877 | |
Dr. Neri Maria Blanco-cuevas, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4441 S Eastern Ave, Las Vegas, NV 89119 Phone: 702-240-6374 Fax: 702-453-6374 | |
Hannah M. Nemec, MD Surgery Medicare: Medicare Enrolled Practice Location: 1707 W Charleston Blvd Ste 160, Las Vegas, NV 89102 Phone: 702-671-5150 | |
Kitae Kim, MD Surgery Medicare: Medicare Enrolled Practice Location: 3061 S Maryland Pkwy Ste 104, Las Vegas, NV 89109 Phone: 702-629-3771 Fax: 702-438-6666 | |
Eddy H Luh, M.D., Surgery Medicare: Accepting Medicare Assignments Practice Location: 8930 W Sunset Rd Ste 300, Las Vegas, NV 89148 Phone: 702-258-7788 Fax: 702-258-7787 |